Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2000
10/05/2000WO1998041232A3 Compositions for modulating responsiveness to corticosteroids
10/05/2000DE19915576A1 New equilenine derivatives, useful as antioxidative estrogenic hormonal steroids for e.g. prophylactic geriatrics in women and men
10/05/2000CA2383592A1 2384891 acids including open reading frames encoding polypeptides; orfx
10/05/2000CA2368951A1 50 human secreted proteins
10/05/2000CA2368927A1 45 human secreted proteins
10/05/2000CA2368881A1 50 human secreted proteins
10/05/2000CA2368760A1 Flint polypeptide analogs
10/05/2000CA2368719A1 50 human secreted proteins
10/05/2000CA2368657A1 Thrombospondin-2 and uses thereof
10/05/2000CA2368647A1 Viral treatment
10/05/2000CA2368641A1 Use of a lectin or conjugates for modulation of c-fibre activity
10/05/2000CA2368631A1 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof
10/05/2000CA2368616A1 Use of vasopeptidase inhibitors to treat angina pectoris
10/05/2000CA2368597A1 Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation
10/05/2000CA2368469A1 50 human secreted proteins
10/05/2000CA2368460A1 Derivatives of pyrimido¬6,1-a|isoquinolin-4-one
10/05/2000CA2368455A1 4-substituted quinoline derivatives as nk-3 and/or gaba(a) receptor ligands
10/05/2000CA2368376A1 50 human secreted proteins
10/05/2000CA2368090A1 Compounds and methods for treatment of asthma, allergy and inflammatory disorders
10/05/2000CA2367792A1 Liver specific bile acid derivatives of the glucocorticoid antagonist ru486
10/05/2000CA2367766A1 Retro-inverso prosaposin-derived peptides and use thereof
10/05/2000CA2367424A1 Hookworm platelet inhibitor
10/05/2000CA2366604A1 Modulators of polysaccharides and uses thereof
10/05/2000CA2366305A1 Method for expressing proteins
10/05/2000CA2365995A1 Cyclic glycerophosphates and analogs thereof
10/05/2000CA2365401A1 Aryl fused 2,4-disubstituted pyridines: nk3 receptor ligands
10/05/2000CA2364622A1 Nitrogen mustard compounds and prodrugs therefor
10/05/2000CA2364305A1 Isolated dna encoding cullin regulators roc1 and roc2, isolated proteins encoded by the same, and methods utilizing the same
10/05/2000CA2361366A1 Novel compounds
10/04/2000EP1041142A2 Universal donor cells
10/04/2000EP1041083A1 Modified timp
10/04/2000EP1041072A1 Dioxocyclopentyl hydroxamic acids
10/04/2000EP1041068A1 Compounds for treating and preventing diabetic complications
10/04/2000EP1040833A1 Bone resorption suppressing agent
10/04/2000EP1040831A2 Use of corticotropin releasing factor (CRF) antagonists to prevent sudden death
10/04/2000EP1040829A2 Prokinetic agents for treating gastric hypomotility and related disorders
10/04/2000EP1040827A2 Use of 2-alkylpyrrolidines for the treatment of diabetes
10/04/2000EP1040820A1 Cosmetic sunscreen compositions based on synergic filter mixtures and their uses
10/04/2000EP1040194A1 Human signal transduction serine/threonine kinase
10/04/2000EP1040190A1 Serine proteinase inhibitors
10/04/2000EP1040187A2 Human protein kinase and kinase inhibitors
10/04/2000EP1040126A2 Methods for maintaining or restoring tissue-appropriate phenotype of soft tissue cells
10/04/2000EP1040125A1 Glucose regulated gene
10/04/2000EP1040112A1 Imidazonaphthyridines and their use in inducing cytokine biosynthesis
10/04/2000EP1040111A1 Integrin receptor antagonists
10/04/2000EP1040108A1 Ortho-anthranilamide derivatives as anti-coagulants
10/04/2000EP1040106A1 Carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonists
10/04/2000EP1040101A1 Substituted 2-aryl-4-amino-chinazolines, method for the production and use thereof as medicaments
10/04/2000EP1040099A1 Azepine or larger medium ring derivatives and their use as pharmaceuticals
10/04/2000EP1040098A1 Integrin receptor antagonists
10/04/2000EP1040096A1 Neuroprotective agents
10/04/2000EP1040095A1 Cyclohexene carboxylates as neuraminidase inhibitors
10/04/2000EP1040094A1 Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
10/04/2000EP1039934A1 Gene therapy approaches to supply apolipoprotein a-i agonists and their use to treat dyslipidemic disorders
10/04/2000EP1039923A1 Gamma-conopeptides
10/04/2000EP1039922A1 Improved interferon polymer conjugates
10/04/2000EP1039916A2 Use of fucane for regulating the reconstruction of connective tissues
10/04/2000EP1039915A1 Cyclic phosphonate ester inhibitors of microsomal triglyceride transfer protein and method
10/04/2000EP1039912A1 Angiostatic agents and compositions for controlling ocular hypertension
10/04/2000EP1039911A1 MORPHOLINO-N-ETHYL ESTER PRODRUGS OF INDOLE sPLA 2 INHIBITORS
10/04/2000EP1039910A1 Use of quinazoline derivatives as tyrosine kinase inhibitors for treating colonic polyps
10/04/2000EP1039908A1 Molecular dispersion composition with enhanced bioavailability
10/04/2000EP1039907A1 Thrombin inhibitors
10/04/2000EP1039906A1 Novel metal complexes
10/04/2000EP1039903A1 Il-8 receptor antagonists
10/04/2000EP1039893A1 Pharmaceutical compositions containing an omega-3 fatty acid oil
10/04/2000EP1039892A2 Use of polyunsaturated fatty acids for reducing the incidence of necrotizing enterocolitis
10/04/2000EP1039889A1 Immunoglobulin-rich milk, production and use thereof
10/04/2000EP1039884A1 A method for the prevention and treatment of stunned myocardium
10/04/2000EP1039804A1 Method for treating fibroproliferative disorders by inhibitors of protein hydroxylation
10/04/2000EP0772610B1 Dihydrobenzofuranes
10/04/2000EP0766672B1 Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors
10/04/2000EP0765311B1 4-aryl-1-(indanmethyl, dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl)piperidines, tetrahydropyridines or piperazines
10/04/2000EP0708773B1 Fused cycloalkylimidazopyridines
10/04/2000CN1268889A Novel process for obtg. intermediates
10/04/2000CN1268352A Method for preparing medicinal prepns. contg. 6-heterocycle-4-amino-1,3,4,5-tetrabenzo [cd] indole
10/04/2000CN1057085C Heterocyclically substituted phenyl-cyclohexane carboxylcic acid derivatives
10/04/2000CN1056973C Pharmaceutical composition to enhance tissue healing and regeneration and application kit comprising it
10/03/2000US6128582 Molecules comprising an IMPDH-like binding pocket and encoded data storage medium capable of graphically displaying them
10/03/2000US6127542 Chemical intermediates to specified pyrazino(2',1':6,1)pyrido(3,4b)indole-1,4-diones which are selective inhibitors of cyclic guanosine 3',5'-monophosphate specific phosphodiesterase; to treat cardiovascular disorders
10/03/2000US6127533 2'-O-aminooxy-modified oligonucleotides
10/03/2000US6127519 Calcitonin derivatives
10/03/2000US6127427 Active hydroxamic acids involved in tissue degradtion and also are inhibitors of the release of tumour necrosis factor from cells; rheumatoid arthritis, osteoarthritis, osteopenias such as osteoporosis, periodontitis, vision defects
10/03/2000US6127426 Antiallergic and -inflammatory agents e.g., treating psoriasis, blocked on the c-10 by a nonphenolic arylacyl or a phenylalkylidene group; lipoxygenase inhibitors; antiproliferative agents; low dosage; side effect reduction
10/03/2000US6127408 Thioether furan nitrone compounds; nervous system degenerative disorders, e.g. alzheimer's disease; analysis of free radicals by forming adducts; inhibit the forming of a beta(1-42) beta-pleated sheets and/or suppressing cytokines
10/03/2000US6127403 An enzyme inhibitor for treating arteriosclerotic lesions of arteriosclerosis, hyperlipemia and diabetes, as well as ischemic diseases of brain, heart
10/03/2000US6127402 5-aroylpyrrol-2-ylmethylarene derivatives
10/03/2000US6127401 Treatment of prostate disorders, angiogenic disorders, neoplasia, rheumatoid arthritis, pulmonary fibrosis, myelofibrosis, abnormal wound healing, atherosclerosis, or restenosis, alzheimer's disease
10/03/2000US6127398 An enzyme inhibitor for the inhibition of phosphodiesterase typeiv or the production of tumor necrosis factor in a mammal; treating asthma, arthritis, bronchitis, chronic obstructive airway disease, psoriasis, allergic rhinitis
10/03/2000US6127396 Imidazoline compounds
10/03/2000US6127389 Benzimidazole derivatives as bradykinin agonists
10/03/2000US6127386 Stimulants, neurotransmitters, cholinergic agents
10/03/2000US6127382 An antiproliferative agent for treating skin-related diseases, an antitumor agent treating cancer, an antiinflammatory agent treating pulmonary fibrosis, ileitis, colitis and krohn's disease
10/03/2000US6127376 Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants
10/03/2000US6127375 A 4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinthiones for treating viral infection
10/03/2000US6127372 Sulfonamide inhibitors of aspartyl protease
10/03/2000US6127371 Endothelin receptor antagonists
10/03/2000US6127367 Administering an aldose reductase inhibitor as an antiischemic agent
10/03/2000US6127365 Tachykinin antagonists for treatment of pain, inflammation, migraine, emesis and postherpetic neuralgia.
10/03/2000US6127357 N-((phenyl, benzodioxinyl or N-heteroarylpiperazinyl)alkyl)-N-(N-heteroaryl)substituted carboxamides
1 ... 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 ... 1564